Canada’s Drug Agency is a pan-Canadian health organization.

Created and funded by Canada’s federal, provincial, and territorial governments, we’re responsible for driving better coordination, alignment, and public value within Canada’s drug and health technology landscape.

We provide Canada’s health system leaders with independent evidence and advice so they can make informed drug, health technology, and health system decisions, and we collaborate with national and international partners to enhance our collective impact.

Community & Lifestyle

Health Care

Non Profit

Canada's Drug Agency

Suzanne Mcgurn

Trupti Desale

Bernice Tsoi

Vijay Shukla

Sinwan Basharat

Sanja Milanovic

Luiza Grazziotin

Ian Johns

Dr. Sandor Demeter

Chanh-Phong (Phong) Tran

Amin A.

Arni Ahronson

Megan Ashlee Bowes

Sudha Kutty

Peter Chinneck

Lillian Chan

Kathleen Kulyk

Heather Logan

Dr. Nicole Mittmann

The Health Economics Team at Canada’s Drug Agency is responsible for evaluating the economic impact of drugs and health technologies. They conduct robust analyses and modeling to provide evidence-based recommendations that inform decision-making within the health system. Collaborating with various stakeholders, the team aims to optimize healthcare resources and enhance the overall value of health interventions in Canada.

Health Economics Team

Clinical Research Team

Project Management Team

Health Economics Team

About

Team members

Other teams at Canada's Drug Agency

Clinical Research Team

Project Management Team